Drugmaker AstraZeneca (NASDAQ:AZN) has drafted plans to spin off its China business and list it as a separate company in Hong Kong or Shanghai, ... ( read original story ...)
Their parents made China the world’s factory. Can the kids save the family business?
When Steven Du took over his parents' factory producing temperature control systems in Shanghai, one of the first changes he made was to turn on the plant's heating in winter - something his frugal ... ( read original story ...)
AstraZeneca Drafts Plan to Spin Off China Business, FT Says
AstraZeneca Plc has drawn up plans to spin off its China business and list it separately in Hong Kong, the Financial Times reported, citing people familiar with the talks. ( read original story ...)
AstraZeneca drafts plan to spin off China business amid tensions
AstraZeneca has drawn up plans to break out its China business and list it separately in Hong Kong as a way to shelter the company against mounting geopolitical tensions. ( read original story ...)
AstraZeneca planning China business spin off -FT
Drugmaker AstraZeneca is drafting a plan to spin off its China business, and listing a separate unit in Hong Kong is being viewed as an option, the Financial Times reported on Sunday. ( read original story ...)
Syngenta’s $9bn IPO approved by Shanghai Exchange
Agrichemical supplier Syngenta Group Friday received Friday the go-ahead to list on the Shanghai Stock Exchange, with the aim of raising 65 billion yuan ($9.1 billion) in what would be the one of ... ( read original story ...)
Is doing business in China becoming impossible for foreigners?
The space for foreigners doing business in China was already being constrained by restrictions that their own governments, led by America’s, have placed on Chinese companies amid rising geopolitical ... ( read original story ...)